Market Place
Sourcing Support
Atossa & Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen
28 Jun 2023 //
PR NEWSWIRE
Atossa enrols pharmacokinetic cohort in breast cancer drug trial
13 Jun 2023 //
CLINICAL TRIALS ARENA
Societal CDMO Enters Agreement With Atossa Therapeutics
23 May 2023 //
GLOBENEWSWIRE
Atossa & Quantum Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen
21 Mar 2023 //
PR NEWSWIRE
Atossa Therapeutics to Acquire Stake in Privately Held Dynamic Cell Therapies
01 Nov 2022 //
BARRONS
Atossa Therapeutics Updated Endoxifen Safe and Well Tolerated
09 Jun 2021 //
GLOBENEWSWIRE
Atossa`s Shares Jump 35% Ahead of Data on Endoxifen
07 Jun 2021 //
GLOBENEWSWIRE
Atossa Therapeutics Announces Ovarian Cancer Patient has Begun
08 Apr 2021 //
GLOBENEWSWIRE
Atossa Therapeutics Announces Receipt of FDA Safe to Proceed Letter
11 Mar 2021 //
GLOBENEWSWIRE
Atossa Announces Final Results from Phase 1 Clinical Study Showing Safety
25 Feb 2021 //
GLOBENEWSWIRE
Atossa Announces Two-Year Update of FDA-Approved Expanded Access Endoxifen
03 Feb 2021 //
GLOBENEWSWIRE
Atossa Therapeutics Receives Second Positive Interim Safety Study of AT-301
17 Sep 2020 //
GLOBENEWSWIRE
Atossa Therapeutics Announces Positive Interim Safety Assessment
01 Sep 2020 //
GLOBENEWSWIRE
Atossa Announces Enrollment and Dosing Completed in First Group AT-301
17 Aug 2020 //
GLOBENEWSWIRE
Atossa Announces Findings from FDA-Approved Expanded Access Treatment Endoxifen
30 Jul 2020 //
GLOBENEWSWIRE
Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray
21 Jul 2020 //
BIOSPECTRUMASIA
Atossa Announces Successful In Vitro Testing of Nasal Spray Formulation: AT-301
15 Jul 2020 //
GLOBENEWLSWIRE
Atossa Announces Availability of Manuscript on Results from Drug, AT-H201
11 Jun 2020 //
GLOBENEWSWIRE
Atossa Therapeutics Announces Second COVID-19 Therapeutic DevP Program, AT-301
28 May 2020 //
GLOBENEWSWIRE
Atossa Announces Successful In vitro Testing Results of COVID-19 Drug: AT-H201
20 May 2020 //
GLOBENEWSWIRE
Atossa Therapeutics Receives FDA Feedback on Two Ongoing Programs
07 May 2020 //
GLOBENEWSWIRE
Atossa Therapeutics Contracts with NYC + Hospitals/Metropolitan for COVID-19
27 Apr 2020 //
GLOBENEWSWIRE
Atossa Therapeutics Seeks Clinical Investigation Approval from FDA
20 Apr 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.